RxDoctor Payments Data

Dennis Shults

Family Medicine · Brea, CANPI 1043370026

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $285,625 of the $287,262 with a category attached, or 99.4%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 99.9% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $106,103, 5.9 times the $17,875 reported in 2021. Among family medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$287,262in general payments, 2019–2025

Across 132 payments — averaging $2176.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$287K
  • Smith+Nephew$125
  • Novo Nordisk$32

What the payments were for

  • Consulting fees$285,62599%
  • Travel & lodging$1,0040%
  • Food & beverage$1250%
  • Education$5070%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Takeda Pharmaceuticals U.S.A., Inc.130$287,104
Smith+Nephew1$125
Novo Nordisk1$32

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$287,262 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California →

Other family medicine in Brea

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →